LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch, “
Eurofins”), a global leader in bioanalytical testing, announces that it has successfully raised EUR 750m in its latest senior unsecured Euro bond public issuance (the “
Bonds”). These Bonds are the first ones issued by Eurofins since it received an investment grade credit rating by Moody’s and Fitch rating agencies. The Bonds have a 10-year maturity (due on 19 May 2031) and will bear an annual fixed rate coupon of 0.875%. The transaction was well received and was more than 1.6x over-subscribed.
As announced on 10 May 2021, the use of proceeds of those bonds is to pro-actively manage the refinancing of its outstanding Euro 353.6m Bonds (ISIN: XS1268496640) due 30 January 2023 (the “